ESALF Eisai Co. Ltd

USD 41.68 -0.67 -1.577332
Icon

Eisai Co. Ltd (ESALF) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NYE
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 41.68

-0.67 (-1.58)%

USD 12.10B

392.00

N/A

N/A

Icon

ESALF

Eisai Co. Ltd (USD)
COMMON STOCK | NYE
USD 41.68
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 12.10B

N/A

USD 41.68

Eisai Co. Ltd (ESALF) Stock Forecast

N/A

Based on the Eisai Co. Ltd stock forecast from 0 analysts, the average analyst target price for Eisai Co. Ltd is not available over the next 12 months. Eisai Co. Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Eisai Co. Ltd is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Eisai Co. Ltd’s stock price was USD 41.68. Eisai Co. Ltd’s stock price has changed by -0.76% over the past week, +1.76% over the past month and -24.35% over the last year.

No recent analyst target price found for Eisai Co. Ltd
No recent average analyst rating found for Eisai Co. Ltd

Company Overview Eisai Co. Ltd

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cel...Read More

https://www.eisai.co.jp

4-6-10, Koishikawa, Tokyo, Japan, 112-8088

11,076

March

USD

USA

Adjusted Closing Price for Eisai Co. Ltd (ESALF)

Loading...

Unadjusted Closing Price for Eisai Co. Ltd (ESALF)

Loading...

Share Trading Volume for Eisai Co. Ltd Shares

Loading...

Compare Performance of Eisai Co. Ltd Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for ESALF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Eisai Co. Ltd (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ZTS
Zoetis Inc +0.70 (+0.42%) USD79.01B 34.04 22.84

ETFs Containing ESALF

Symbol Name ESALF's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Eisai Co. Ltd (ESALF) Stock

Stock Target Advisor's fundamental analysis for Eisai Co. Ltd's stock is Neutral.

ESALF stock's dividend yield is 2.79%. Our analysis grades ESALF stock's dividend yield at D+. This means that ESALF stock's dividend yield is above 67% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange. Based on this ESALF may be a average dividend stock for its sector.

Unfortunately we do not have enough data on ESALF's stock to indicate what its average analyst target is.

ESALF stock's Price/Earning ratio is 40.18. Our analysis grades ESALF stock's Price / Earning ratio at F. This means that ESALF stock's Price/Earning ratio is above 61% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NYE exchange. Based on this ESALF may be a overvalued for its sector.

The last closing price of ESALF's stock was USD 41.68.

The most recent market capitalization for ESALF is USD 12.10B.

Unfortunately we do not have enough analyst data on ESALF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Eisai Co. Ltd's stock.

As per our most recent records Eisai Co. Ltd has 11,076 Employees.

Eisai Co. Ltd's registered address is 4-6-10, Koishikawa, Tokyo, Japan, 112-8088. You can get more information about it from Eisai Co. Ltd's website at https://www.eisai.co.jp.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...